Search results for: 'pace pharmaceutical'
- Did you mean
- pacif pharmaceutical
- part pharmaceutical
- Related search terms
- pharmaceutical-industry-in-ghana-and-nigeria-18447
- pharmaceutical membrane filtration market analysis by product mce coated cellulose acetate nylon p1df membrane technique
- pharmaceutical R&D service market
- pharmaceutical industry market size of singapor
- pace of care testing market global 2014 2026
-
05 May 2020  |  North America  |  Frost Radar
FROST RADAR™: Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry, 2020
Benchmarking Future Growth Potential
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...
$4,950.00 -
14 Oct 2019  |  North America  |  Technology Research
Innovations in Biomarker Analytics
Tracking the Market Landscape of Companies Striving to Derive Actionable Insights from the Data Deluge through the incorporation of Artificial Intelligence
Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...
$4,950.00 -
29 Sep 2023  |  North America  |  Market Research
Generative Artificial Intelligence Growth Opportunities in the Healthcare and Life Science Industry
Possibilities Exist to Adapt Large Language Models and Reinvent Enterprise Functions
This project provides an overview of the effects of generative AI (Gen AI) on the healthcare and life science industry and numerous growth opportunities, including how it could overcome regulatory and cybersecurity obstacles, address the build-borrow-buy conundrum, and impact the value chain of pharmaceutical companies, medical device developers, p...
$2,450.00 -
25 Apr 2022  |  North America  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...
$4,950.00 -
05 Feb 2021  |  North America  |  Market Research
Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market
Early-stage R&D and Commercial Applications Fuel the Growth Pipeline
The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...
$4,950.00 -
23 Feb 2021  |  North America  |  Market Research
AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market
Increased Demand for Remote Pathology Services and Centralization of Digital Pathology Workflow in Hospital Networks to Spark New Growth Opportunities
The Transformational Health team at Frost & Sullivan provides critical insights into the global digital pathology market, highlighting key growth opportunities, market revenue forecast, and business models that will play an essential role in its growth. The study segments the market by product (hardware, software, and storage solutions) and region ...
$4,950.00 -
09 May 2019  |  North America  |  Market Outlook
Global Autonomous Driving (AD) Industry Outlook, 2019
1 in 4 Cars Sold (18 Million) Globally is Expected to be Automated (L3 and Above) by 2030, with L4 Driving the Growth of Ownership
The autonomous driving industry is evolving at a rapid pace on various fronts such as advancements in technology as well as emergence of new business models. Traditionally, most major OEMs and Tier I suppliers have strived to explore the benefits of developing applications focused on the convergence of the three technology pillars: Connected, Auton...
$4,950.00 -
11 Apr 2019  |  North America  |  Market Research
Pharma Clinical Trial Digitization—Companies to Action, 2019
Collision of Healthcare with Life Sciences IT Systems will Continue to Transform the Clinical Trials Market
Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...
$1,500.00 -
21 May 2019  |  North America  |  Market Outlook
Global UCC Industry Outlook, 2019
Rich Media Capabilities Shine in the Next-gen Workplace
The global UCC market continues to evolve at a rapid pace. Migration to cloud-based subscription services is accelerating as organizations gain confidence, existing CPE assets near end of life, and current cloud services deployments expand to more sites, users and applications. The gap between “as a service” offerings and other consumption model...
$4,950.00 -
20 Sep 2021  |  North America  |  Market Research
Global In Vitro Diagnostics Market Outlook, 2021
Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic
The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...
$4,950.00